Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TRDA is expected to report earnings to fall 2,547.00% to -73 cents per share on May 08

Entrada Therapeutics TRDA Stock Earnings Reports

Q1'25

Est.

$-0.73

Q4'24

Beat

by $0.70

Q3'24

Beat

by $0.38

Q2'24

Beat

by $1.19

Q1'24

Beat

by $1.27

The last earnings report on March 03 showed earnings per share of 2 cents, beating the estimate of -67 cents. With 2.23K shares outstanding, the current market capitalization sits at 330.83M.

View a ticker or compare two or three

Compare

TRDA